The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Simple cognitive test and EMR tool boost dementia care actions in primary care setting, trial finds
By
Kristen Fischer
Jun 07, 2024
A five-minute cognitive assessment test and an electronic medical record (EMR) decision-making add-on system improved dementia diagnosis and care, according to a clinical trial.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Nonwhite adults with cognitive impairment more likely to live in polluted areas
May 21, 2024
The authors say that clinical trials should consider environmental exposures and injustices.
Facility staff and families both struggle to figure out processes for dementia patients, report reveals
By
Kimberly Bonvissuto
Mar 20, 2024
It’s not just family caregivers who face challenges navigating dementia care — the nation’s healthcare workers also said they had difficulties providing care coordination through a complex healthcare...
Cognitive deficits seen in COVID-19 patients regardless of symptom duration
Feb 29, 2024
Compared with those without COVID-19, similar deficits were seen for those in whom symptoms resolved in less than four or at least 12 weeks.
New app puts popular cognitive assessment tool onto smartphones
By
Aaron Dorman
Feb 23, 2024
A new app allows users to take a rapid version of the Montreal Cognitive Assessment on their smartphone, for early warning signs of dementia.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Cognitive symptoms common with post-COVID-19 condition
Feb 15, 2024
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.